Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. (2024)

First Author: Rosoff DB
Attributed to:  BUD23 drives system-wide adaptations to energy metabolism funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circgen.122.004224

PubMed Identifier: 38258565

Publication URI: http://europepmc.org/abstract/MED/38258565

Type: Journal Article/Review

Parent Publication: Circulation. Genomic and precision medicine

ISSN: 2574-8300